this mornings news, page-8

Current standard mesothelioma treatments extend life by months . I they can even acheive 1/2 of those animal results in humans then it will go to market at warp speed IMHO. Research gleevec approval in multiple myeloma to se how quick it can happen . Once approvd it can be used "off label" , which is common , against other cancers . It has shown to be effective against the more common cancers , such as NSCLC , giving it blockbuster potential . With no serious side effects I cant see how it can lose . Cheers .